DEX yields 2.60% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 8
Combined, DEX + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DEX + JNJ for your $10,000?
Delaware Enhanced Global Dividend and Income Fund is a closed ended balanced mutual fund launched by Delaware Management Holdings, Inc. The fund is managed by Delaware Management Business Trust. It invests in public equity and fixed income markets across the globe. The fund seeks to invest in securities of companies operating across diversified sectors. It primarily invests in dividend paying stocks of large-cap companies. For its fixed income portion, the fund invests in debt securities such as government bonds, investment grade and high risk, high yield corporate bonds, and convertible bonds. It also invests in emerging market securities. The fund benchmarks the performance of its portfolio against the S&P 500 Index, the Lipper Closed-End Global Funds Average, the FTSE EPRA/NAREIT Developed Index, and the BoFA Merrill Lynch U.S. High Yield Constrained Index. Delaware Enhanced Global Dividend and Income Fund was formed on June 29, 2007 and is domiciled in the United States.
Full DEX Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.